+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cementless total knee arthroplasty Market Size, Share & Industry Trends Analysis Report By Product (Fixed Bearing, and Mobile Bearing), By End User (Hospitals, and Others), By Material (Alloys, Ceramics, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 116 Pages
  • August 2023
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5886879
The Latin America, Middle East and Africa Cementless Total Knee Arthroplasty Market should witness market growth of 8.7% CAGR during the forecast period (2023-2030).

For patients having primary total knee arthroplasty (TKA), cementless fixation is a dependable, long-lasting fixation alternative. It is particularly appealing to patients who are younger and more active. Modern, highly porous metals and other advancements in fixing materials act as an extra tool for osseointegration promotion and longer-term success. Due to the possibility of biological attachment and increased survival, cementless prostheses continue to be a fascinating choice. The substance used to create cementless implants draws in fresh bone growth. Most are coated or textured so that new bone forms on the implant's surface.

With enhanced osseointegration giving biological attachment, improved surgical efficiency, and fewer systemic problems related to cement impaction as well as wear from cement debris, cementless total knee arthroplasty has recently had an increase in adoption. There is hope that cementless fixation may enhance implant survival and functional outcomes as younger and more active patients increasingly request knee arthroplasty. The substance used to create cementless implants draws in fresh bone growth. Most are coated or textured so that new bone forms on the implant's surface.

According to the National Library of Medicine, the prevalence of overweight as well as obesity, respectively, is 23.5-62.1 and 14.5-40.6 in the Middle East. According to the same source, Israel, Kuwait, and Syria had the highest rates of obesity and overweight people. The rise in the incidence of non-communicable diseases, such as obesity, may be attributed to changes in lifestyle over the previous few years, such as Arabic diets (high-calorie, fatty meals like fast food), alcohol drinking, and decreased physical activity. This indicates that such metabolic mediators contribute to a rise in the incidence of osteoarthritis in obese patients. Hence, the increasing burden of obesity and overweight in this region may result in a greater prevalence of orthopedic issues, which in turn will drive the regional market.

The Brazil market dominated the LAMEA Cementless Total Knee Arthroplasty Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $47.6 Million by 2030. The Argentina market is showcasing a CAGR of 9.3% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.4% during (2023-2030).

Based on Product, the market is segmented into Fixed Bearing, and Mobile Bearing. Based on End-user, the market is segmented into Hospitals, and Others. Based on Material, the market is segmented into Alloys, Ceramics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew PLC, Stryker Corporation, Olympus Corporation, Zimmer Biomet Holdings, Inc., MicroPort Scientific Corporation, United Orthopedic Corporation (Chi-Yi Investment Co. Ltd.), X.NOV and Waldemar Link GmbH & Co. KG.

Scope of the Study

By Product

  • Fixed Bearing
  • Mobile Bearing

By End-user

  • Hospitals
  • Others

By Material

  • Alloys
  • Ceramics
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson
  • B.Braun Melsungen AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Olympus Corporation
  • Zimmer Biomet Holdings, Inc.
  • MicroPort Scientific Corporation
  • United Orthopedic Corporation (Chi-Yi Investment Co. Ltd.)
  • X.NOV
  • Waldemar Link GmbH & Co. KG

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cementless total knee arthroplasty Market, by Product
1.4.2 LAMEA Cementless total knee arthroplasty Market, by End User
1.4.3 LAMEA Cementless total knee arthroplasty Market, by Material
1.4.4 LAMEA Cementless total knee arthroplasty Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. LAMEA Cementless Total Knee Arthroplasty Market by Product
4.1 LAMEA Fixed Bearing Market by Country
4.2 LAMEA Mobile Bearing Market by Country
Chapter 5. LAMEA Cementless Total Knee Arthroplasty Market by End User
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Others Market by Country
Chapter 6. LAMEA Cementless Total Knee Arthroplasty Market by Material
6.1 LAMEA Alloys Market by Country
6.2 LAMEA Ceramics Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Cementless Total Knee Arthroplasty Market by Country
7.1 Brazil Cementless Total Knee Arthroplasty Market
7.1.1 Brazil Cementless Total Knee Arthroplasty Market by Product
7.1.2 Brazil Cementless Total Knee Arthroplasty Market by End User
7.1.3 Brazil Cementless Total Knee Arthroplasty Market by Material
7.2 Argentina Cementless Total Knee Arthroplasty Market
7.2.1 Argentina Cementless Total Knee Arthroplasty Market by Product
7.2.2 Argentina Cementless Total Knee Arthroplasty Market by End User
7.2.3 Argentina Cementless Total Knee Arthroplasty Market by Material
7.3 UAE Cementless Total Knee Arthroplasty Market
7.3.1 UAE Cementless Total Knee Arthroplasty Market by Product
7.3.2 UAE Cementless Total Knee Arthroplasty Market by End User
7.3.3 UAE Cementless Total Knee Arthroplasty Market by Material
7.4 Saudi Arabia Cementless Total Knee Arthroplasty Market
7.4.1 Saudi Arabia Cementless Total Knee Arthroplasty Market by Product
7.4.2 Saudi Arabia Cementless Total Knee Arthroplasty Market by End User
7.4.3 Saudi Arabia Cementless Total Knee Arthroplasty Market by Material
7.5 South Africa Cementless Total Knee Arthroplasty Market
7.5.1 South Africa Cementless Total Knee Arthroplasty Market by Product
7.5.2 South Africa Cementless Total Knee Arthroplasty Market by End User
7.5.3 South Africa Cementless Total Knee Arthroplasty Market by Material
7.6 Nigeria Cementless Total Knee Arthroplasty Market
7.6.1 Nigeria Cementless Total Knee Arthroplasty Market by Product
7.6.2 Nigeria Cementless Total Knee Arthroplasty Market by End User
7.6.3 Nigeria Cementless Total Knee Arthroplasty Market by Material
7.7 Rest of LAMEA Cementless Total Knee Arthroplasty Market
7.7.1 Rest of LAMEA Cementless Total Knee Arthroplasty Market by Product
7.7.2 Rest of LAMEA Cementless Total Knee Arthroplasty Market by End User
7.7.3 Rest of LAMEA Cementless Total Knee Arthroplasty Market by Material
Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Smith & Nephew PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional and Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Stryker Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Olympus Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 Zimmer Biomet Holdings, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 MicroPort Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 United Orthopedic Corporation (Chi-Yi Investment Co. Ltd.)
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 X.NOV
8.9.1 Company Overview
8.10. Waldemar Link GmbH & Co. KG
8.10.1 Company Overview
8.10.2 SWOT Analysis

Companies Mentioned

  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Olympus Corporation
  • Zimmer Biomet Holdings, Inc.
  • MicroPort Scientific Corporation
  • United Orthopedic Corporation (Chi-Yi Investment Co. Ltd.)
  • X.NOV
  • Waldemar Link GmbH & Co. KG

Methodology

Loading
LOADING...